US Stock MarketDetailed Quotes

CNBX CNBX Pharmaceuticals

Watchlist

0.006000
+0.000200+3.45%

15min DelayClose Jul 22 16:00 ET

186.67KMarket Cap0.02P/E (TTM)

CNBX Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)May 31, 2024

(Q2)Feb 29, 2024

(Q1)Nov 30, 2023

(FY)Aug 31, 2023

(Q4)Aug 31, 2023

(Q3)May 31, 2023

(Q2)Feb 28, 2023

(Q1)Nov 30, 2022

(FY)Aug 31, 2022

(Q4)Aug 31, 2022

Total revenue

40.64K

89.44K

1,269.13%410.17K

233.80%100K

310.17K

29.96K

Operating revenue

--0

--40.64K

--89.44K

1,269.13%410.17K

233.80%100K

--310.17K

--0

--29.96K

Cost of revenue

6.22K

Gross profit

34.42K

Operating expense

-68.49%152.28K

-3.67%240.85K

-24.64%261.34K

-55.04%1.34M

-48.56%261.5K

-23.90%483.25K

-65.76%250.01K

-68.77%346.79K

14.76%2.98M

-14.76%508.31K

Selling and administrative expenses

-50.31%109.39K

-43.77%133.65K

-47.55%148.92K

-49.46%909.98K

-51.19%168.26K

-42.96%220.13K

-40.53%237.68K

-57.65%283.9K

117.30%1.8M

175.06%344.71K

-Selling and marketing expense

----

-92.35%1.22K

----

-21.08%15.98K

----

-General and administrative expense

-50.31%109.39K

-43.77%133.65K

-47.55%148.92K

-49.08%908.76K

-49.19%167.04K

-42.96%220.13K

-40.53%237.68K

-57.65%283.9K

120.77%1.78M

212.85%328.74K

Research and development costs

-83.70%42.88K

769.56%107.2K

78.76%112.42K

-63.53%431.57K

-43.01%93.24K

5.64%263.12K

-96.27%12.33K

-85.71%62.89K

-33.21%1.18M

-65.27%163.6K

Operating profit

12.02%-152.28K

17.43%-206.43K

50.43%-171.9K

68.47%-931.38K

66.24%-161.5K

72.74%-173.08K

65.76%-250.01K

68.77%-346.79K

-13.61%-2.95M

19.78%-478.35K

Net non-operating interest income expense

17.69%21.65K

-77.70%4.68K

39.12%-6.62K

7.78%-1.17K

96.14%-29.67K

-60.57%18.39K

104.13%20.99K

94.88%-10.88K

97.93%-1.27K

-219.44%-769.2K

Non-operating interest expense

----

-39.12%6.62K

-7.78%1.17K

----

-94.88%10.88K

-46.76%1.27K

----

Total other finance cost

-17.69%-21.65K

77.70%-4.68K

----

60.57%-18.39K

-104.13%-20.99K

----

Other net income (expense)

94.84%-123.71K

-93.28%-2.78M

-382.38K

-2.4M

-169.69%-1.44M

Gain on sale of security

----

105.74%3.36K

----

-133.66%-58.57K

----

Special income (charges)

--0

94.84%-123.71K

----

-315.37%-2.73M

49.58%-330.93K

--0

---2.4M

----

---656.33K

-234.92%-656.33K

-Gain on sale of property,plant,equipment

--0

94.84%-123.71K

----

-315.37%-2.73M

49.58%-330.93K

--0

---2.4M

----

---656.33K

-234.92%-656.33K

Other non- operating income (expenses)

----

92.41%-54.81K

----

-2.17%-722.24K

----

Income before tax

15.55%-130.63K

87.60%-325.46K

50.09%-178.52K

15.53%-3.71M

78.64%-573.55K

73.71%-154.69K

-111.83%-2.62M

72.97%-357.67K

-37.50%-4.39M

-294.14%-2.68M

Income tax

Net income

15.55%-130.63K

87.60%-325.46K

50.09%-178.52K

15.53%-3.71M

50.08%-573.55K

77.31%-154.69K

-111.83%-2.62M

72.97%-357.67K

-37.50%-4.39M

-68.66%-1.15M

Net income continuous Operations

15.55%-130.63K

87.60%-325.46K

50.09%-178.52K

15.53%-3.71M

50.08%-573.55K

77.31%-154.69K

-111.83%-2.62M

72.97%-357.67K

-37.50%-4.39M

-68.66%-1.15M

Minority interest income

Net income attributable to the parent company

15.55%-130.63K

87.60%-325.46K

50.09%-178.52K

15.53%-3.71M

50.08%-573.55K

77.31%-154.69K

-111.83%-2.62M

72.97%-357.67K

-37.50%-4.39M

-68.66%-1.15M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

15.55%-130.63K

87.60%-325.46K

50.09%-178.52K

15.53%-3.71M

50.08%-573.55K

77.31%-154.69K

-111.83%-2.62M

72.97%-357.67K

-37.50%-4.39M

-68.66%-1.15M

Basic earnings per share

79.01%-0.0042

99.25%-0.01

99.70%-0.001

88.30%-0.42

97.30%-0.0254

96.37%-0.02

-31.68%-1.33

72.50%-0.33

-49.58%-3.59

-394.74%-0.94

Diluted earnings per share

79.01%-0.0042

99.25%-0.01

99.70%-0.001

88.30%-0.42

97.30%-0.0254

96.37%-0.02

-31.68%-1.33

72.50%-0.33

-49.58%-3.59

-394.74%-0.94

Dividend per share

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)May 31, 2024	(Q2)Feb 29, 2024	(Q1)Nov 30, 2023	(FY)Aug 31, 2023	(Q4)Aug 31, 2023	(Q3)May 31, 2023	(Q2)Feb 28, 2023	(Q1)Nov 30, 2022	(FY)Aug 31, 2022	(Q4)Aug 31, 2022
Total revenue	0	40.64K	89.44K	1,269.13%410.17K	233.80%100K	310.17K	0	0	29.96K	29.96K
Operating revenue	--0	--40.64K	--89.44K	1,269.13%410.17K	233.80%100K	--310.17K	--0	--0	--29.96K	--29.96K
Cost of revenue		6.22K					0
Gross profit		34.42K					0
Operating expense	-68.49%152.28K	-3.67%240.85K	-24.64%261.34K	-55.04%1.34M	-48.56%261.5K	-23.90%483.25K	-65.76%250.01K	-68.77%346.79K	14.76%2.98M	-14.76%508.31K
Selling and administrative expenses	-50.31%109.39K	-43.77%133.65K	-47.55%148.92K	-49.46%909.98K	-51.19%168.26K	-42.96%220.13K	-40.53%237.68K	-57.65%283.9K	117.30%1.8M	175.06%344.71K
-Selling and marketing expense	----	----	----	-92.35%1.22K	----	----	----	----	-21.08%15.98K	----
-General and administrative expense	-50.31%109.39K	-43.77%133.65K	-47.55%148.92K	-49.08%908.76K	-49.19%167.04K	-42.96%220.13K	-40.53%237.68K	-57.65%283.9K	120.77%1.78M	212.85%328.74K
Research and development costs	-83.70%42.88K	769.56%107.2K	78.76%112.42K	-63.53%431.57K	-43.01%93.24K	5.64%263.12K	-96.27%12.33K	-85.71%62.89K	-33.21%1.18M	-65.27%163.6K
Operating profit	12.02%-152.28K	17.43%-206.43K	50.43%-171.9K	68.47%-931.38K	66.24%-161.5K	72.74%-173.08K	65.76%-250.01K	68.77%-346.79K	-13.61%-2.95M	19.78%-478.35K
Net non-operating interest income expense	17.69%21.65K	-77.70%4.68K	39.12%-6.62K	7.78%-1.17K	96.14%-29.67K	-60.57%18.39K	104.13%20.99K	94.88%-10.88K	97.93%-1.27K	-219.44%-769.2K
Non-operating interest expense	----	----	-39.12%6.62K	-7.78%1.17K	----	----	----	-94.88%10.88K	-46.76%1.27K	----
Total other finance cost	-17.69%-21.65K	77.70%-4.68K	----	----	----	60.57%-18.39K	-104.13%-20.99K	----	----	----
Other net income (expense)		94.84%-123.71K		-93.28%-2.78M	-382.38K		-2.4M		-169.69%-1.44M
Gain on sale of security	----	----	----	105.74%3.36K	----	----	----	----	-133.66%-58.57K	----
Special income (charges)	--0	94.84%-123.71K	----	-315.37%-2.73M	49.58%-330.93K	--0	---2.4M	----	---656.33K	-234.92%-656.33K
-Gain on sale of property,plant,equipment	--0	94.84%-123.71K	----	-315.37%-2.73M	49.58%-330.93K	--0	---2.4M	----	---656.33K	-234.92%-656.33K
Other non- operating income (expenses)	----	----	----	92.41%-54.81K	----	----	----	----	-2.17%-722.24K	----
Income before tax	15.55%-130.63K	87.60%-325.46K	50.09%-178.52K	15.53%-3.71M	78.64%-573.55K	73.71%-154.69K	-111.83%-2.62M	72.97%-357.67K	-37.50%-4.39M	-294.14%-2.68M
Income tax
Net income	15.55%-130.63K	87.60%-325.46K	50.09%-178.52K	15.53%-3.71M	50.08%-573.55K	77.31%-154.69K	-111.83%-2.62M	72.97%-357.67K	-37.50%-4.39M	-68.66%-1.15M
Net income continuous Operations	15.55%-130.63K	87.60%-325.46K	50.09%-178.52K	15.53%-3.71M	50.08%-573.55K	77.31%-154.69K	-111.83%-2.62M	72.97%-357.67K	-37.50%-4.39M	-68.66%-1.15M
Minority interest income
Net income attributable to the parent company	15.55%-130.63K	87.60%-325.46K	50.09%-178.52K	15.53%-3.71M	50.08%-573.55K	77.31%-154.69K	-111.83%-2.62M	72.97%-357.67K	-37.50%-4.39M	-68.66%-1.15M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	15.55%-130.63K	87.60%-325.46K	50.09%-178.52K	15.53%-3.71M	50.08%-573.55K	77.31%-154.69K	-111.83%-2.62M	72.97%-357.67K	-37.50%-4.39M	-68.66%-1.15M
Basic earnings per share	79.01%-0.0042	99.25%-0.01	99.70%-0.001	88.30%-0.42	97.30%-0.0254	96.37%-0.02	-31.68%-1.33	72.50%-0.33	-49.58%-3.59	-394.74%-0.94
Diluted earnings per share	79.01%-0.0042	99.25%-0.01	99.70%-0.001	88.30%-0.42	97.30%-0.0254	96.37%-0.02	-31.68%-1.33	72.50%-0.33	-49.58%-3.59	-394.74%-0.94
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall